Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands › Research Explorer

DOI

https://doi.org/10.1016/S2665-9913(21)00222-8
Final published version

Laura Boekel
Maurice Steenhuis
Femke Hooijberg
Yaëlle R. Besten
Olvi Cristianawati
Sofie Keijzer
Alexandre E. Voskuyl
Joep Killestein
Maarten Boers

Original language	English
Pages (from-to)	e778-e788
Journal	The Lancet Rheumatology
Volume	3
Issue number	11
DOIs	https://doi.org/10.1016/S2665-9913(21)00222-8
Publication status	Published - 1 Nov 2021

ID: 20568979